Targeted therapies for T-cell acute lymphoblastic leukaemia (T-ALL): what makes T-ALL TYK?

about

Targeted therapies for T-cell acute lymphoblastic leukaemia (T-ALL): what makes T-ALL TYK?

Item

http://www.wikidata.org/entity/Q54479682

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Targeted therapies for T-cell ...... (T-ALL): what makes T-ALL TYK?

@en

Targeted therapies for T-cell acute lymphoblastic leukaemia

@nl

type

Item

label

Targeted therapies for T-cell ...... (T-ALL): what makes T-ALL TYK?

@en

Targeted therapies for T-cell acute lymphoblastic leukaemia

@nl

prefLabel

Targeted therapies for T-cell ...... (T-ALL): what makes T-ALL TYK?

@en

Targeted therapies for T-cell acute lymphoblastic leukaemia

@nl

P1476

Targeted therapies for T-cell ...... (T-ALL): what makes T-ALL TYK?

@en

P2093

David J Curtis

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model

Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia

Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function.

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia

Cancer cell lines for drug discovery and development.

Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences.

P304

169-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/BJH.14559

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

David J Curtis

P577

2017-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28211568

http://www.w3.org/2001/XMLSchema#string

P921

leukemia